Company intelligence / Profile preview

Mile High Labs

Loveland, Colorado, United Statesmilehighlabs.com ↗

Ownership: Private
Employees: ~57
Development stage: Commercial

Overview

Mile High Labs is a global leader in the manufacture of hemp-derived cannabinoid ingredients such as CBD isolate and CBG isolate. The company has achieved significant regulatory milestones including being the first hemp-derived CBD manufacturer to enter the Risk Management Phase of the UK Novel Foods process. It holds GMP and ISO 9001 certifications and supplies over 5,000 businesses worldwide with compliant cannabinoid solutions for food, beverage, cosmetic, nutraceuticals, and pharmaceutical applications.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Chemicals & Materials

Partnerships

No major pharmaceutical or biotech partnerships disclosed; collaborates with global brands in food/beverage/cosmetics/pharma sectors

Beyond the preview

Go deeper on Mile High Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mile High Labs.

Explore the full profile